Naschitz Brandes Amir Represents MeMed Diagnostics Ltd. in its $70 Million Financing Round
MeMed, an Israeli biomedical company that developed a unique blood test for rapid diagnosis ‚Äčof a bacterial or viral infection that can significantly reduce the use of antibiotics, has completed an apporx. $70 million round of financing led by Ping An Global Voyager, Foxconn, Caesarea Medical Electronics Holding (2000) Ltd., Ourcrowd, Phoenix, Clal Insurance, Horizons Ventures, Social Capital +, WTI and private investors.
MeMed was represented by partners Arnon Samburski and Daniela Ben-Shalom and associate Mayrav Danor from our firm. The firm has been representing MeMed since its inception.